Holen Sie sich die Stockscreener-App
1.47
2.08%
0.03
Schlusskurs vom Vortag:
$1.44
Offen:
$1.44
24-Stunden-Volumen:
1.33M
Relative Volume:
0.83
Marktkapitalisierung:
$565.31M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.5474
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+2.08%
1M Leistung:
+25.64%
6M Leistung:
+36.11%
1J Leistung:
-27.23%
1-Tages-Spanne:
$1.43
$1.49
1-Wochen-Bereich:
$1.39
$1.5099
52-Wochen-Spanne:
$0.92
$2.25
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.47 | 553.77M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
Get in on Standard BioTools Inc’s (LAB) buy-in window today! - Setenews
Standard BioTools (NASDAQ:LAB) Director Casdin Partners Master Fund, L Purchases 75,000 Shares - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Purchases 125,000 Shares of Stock - MarketBeat
Insider Buying: Standard BioTools (NASDAQ:LAB) Director Acquires 150,000 Shares of Stock - MarketBeat
Standard BioTools Inc. Stock (LAB) Opinions on Insider Purchases - Quiver Quantitative
Subdued Growth No Barrier To Standard BioTools Inc. (NASDAQ:LAB) With Shares Advancing 26% - simplywall.st
Will Standard BioTools Inc. stock attract ESG investorsQuarterly Growth Report & High Accuracy Buy Signal Tips - Newser
Why Standard BioTools Inc. (FLB) stock is upgraded to buy2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser
Casdin funds buy Standard Biotools (LAB) shares for $502,570 By Investing.com - Investing.com Australia
Casdin funds buy Standard Biotools (LAB) shares for $502,570 - Investing.com
Casdin Capital, LLC Increases Stake in Standard BioTools Inc - GuruFocus
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry - MSN
Why Standard BioTools Inc. (FLB) stock is trending on social mediaEarnings Risk Summary & Free High Return Stock Watch Alerts - Newser
How Standard BioTools Inc. (FLB) stock trades in high volatility2025 Market Sentiment & Daily Price Action Insights - Newser
Why analysts raise outlook for Standard BioTools Inc. (FLB) stock2025 Year in Review & Free High Accuracy Swing Entry Alerts - Newser
Weekly Trades: Will Standard BioTools Inc stock attract ESG investorsJuly 2025 Price Swings & AI Driven Stock Movement Reports - BỘ NỘI VỤ
Published on: 2025-12-01 23:56:21 - Newser
BioTools Inc.: A Deep Dive (NASDAQ:LAB) - Seeking Alpha
Will Standard BioTools Inc. stock outperform growth indexesJuly 2025 Setups & Free Long-Term Investment Growth Plans - BỘ NỘI VỤ
Standard BioTools (NASDAQ:LAB) Director Acquires $214,500.00 in Stock - MarketBeat
Casdin Partners Master Fund, L Buys 7,550,000 Shares of Standard BioTools (NASDAQ:LAB) Stock - MarketBeat
Can Standard BioTools Inc. stock sustain market leadershipJuly 2025 Movers & Technical Buy Zone Confirmations - BỘ NỘI VỤ
Standard BioTools price target lowered to $1.35 from $1.55 at TD Cowen - MSN
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
Is Standard BioTools Inc. (FLB) stock bottoming after sell offIndex Update & Technical Pattern Recognition Alerts - BỘ NỘI VỤ
Aug Intraday: Can Standard BioTools Inc. stock maintain operating marginsWeekly Stock Summary & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
[Form 4] STANDARD BIOTOOLS INC. Insider Trading Activity - Stock Titan
Standard BioTools (NASDAQ:LAB) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Standard BioTools Inc. (NASDAQ:LAB) Institutional Owners May Be Pleased With Recent Gains After 14% Loss Over the Past Year - 富途牛牛
With Standard BioTools Stock Surging, Have You Considered The Downside? - Trefis
Is Standard BioTools Inc. (FLB) stock considered safe havenJuly 2025 Closing Moves & Free High Return Stock Watch Alerts - newser.com
Casdin funds buy Standard BioTools (LAB) shares for $1.37 million By Investing.com - Investing.com Nigeria
Casdin funds buy Standard BioTools (LAB) shares for $1.37 million - Investing.com
Owner Casdin Partners Master Fund LP Buys 1,075,000 ($1.4M) Of Standard BioTools Inc [LAB] - TradingView
Standard BioTools (LAB) Price Target Decreased by 12.68% to 1.58 - MSN
Is Standard BioTools Inc. stock recession proof2025 Top Decliners & Community Verified Trade Alerts - newser.com
Can Standard BioTools Inc. stock deliver consistent earnings growthJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Is Standard BioTools Inc FLB a good long term investmentDividend Growth Stocks & Low Entry Risk Stocks - earlytimes.in
Will Standard BioTools Inc. (FLB) stock profit from automation waveWeekly Earnings Recap & Weekly Breakout Opportunity Watchlist - newser.com
Top chart patterns to watch in Standard BioTools Inc.2025 Dividend Review & Short-Term High Return Ideas - newser.com
Will Standard BioTools Inc. outperform the marketMarket Trend Summary & Community Verified Trade Signals - newser.com
Understanding Standard BioTools Inc.’s price movementGDP Growth & Weekly Market Pulse Updates - newser.com
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):